These two drugs dont even treat the same point in condition, HGEN treats when hypoxia begins CYDY thinks it might work on critical cases but they have to see how the revised trial goes... So there is plenty of room for both if they both pass the phase 3 studies I still dont have much faith in NP but i think at this point its NP’s baby to live or die. Its too late to change jockeys and even if they wanted to who is going to take the reigns of a company with multiple law suits, debt up to its ears , and a revolving door of real scientists . Isnt Kelly a physiatrist? I found that quite interesting and amusing
News 
Market Data 
Discover 
